As of 2024-12-12, the Fair Value of Adverum Biotechnologies Inc (ADVM) is -22.62 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.89 USD, the upside of Adverum Biotechnologies Inc is -484.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -64.49 | -117.51 | -145.54 | -154.54 | -117.17 | -119.85 |
| YoY growth | 11.21% | -82.22% | -23.86% | -6.18% | 24.18% | -15.37% |
| Market Cap (mil) | 122.51 |
| P/E | |
| Forward P/E |
| EPS | -4.52 |
| Avg earnings growth rate | -15.37% |
| TTM earnings | -94.11 |